High-resolution diffusion-weighted MRI plus mammography for detecting clinically occult breast cancers in women with dense breasts.

[1]  P. Sijens,et al.  Image quality of DWI at breast MRI depends on the amount of fibroglandular tissue: implications for unenhanced screening. , 2023, European radiology.

[2]  M. McEntee,et al.  Examining the effectiveness of supplementary imaging modalities for breast cancer screening in women with dense breasts: A systematic review and meta-analysis. , 2022, European journal of radiology.

[3]  Jie Liu,et al.  High-Resolution DWI with Simultaneous Multi-Slice Readout-Segmented Echo Planar Imaging for the Evaluation of Malignant and Benign Breast Lesions , 2021, Diagnostics.

[4]  Eun Sook Ko,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea , 2021, Journal of breast cancer.

[5]  T. Helbich,et al.  Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy , 2021, Clinical Cancer Research.

[6]  W. Moon,et al.  Simultaneous Multislice Readout‐Segmented Echo Planar Imaging for Diffusion‐Weighted MRI in Patients With Invasive Breast Cancers , 2020, Journal of magnetic resonance imaging : JMRI.

[7]  Hee Jung Shin,et al.  Diffusion-Weighted Magnetic Resonance Imaging of the Breast: Standardization of Image Acquisition and Interpretation , 2020, Korean journal of radiology.

[8]  M. Iima,et al.  Evaluation of Malignant Breast Lesions Using High-resolution Readout-segmented Diffusion-weighted Echo-planar Imaging: Comparison with Pathology , 2020, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[9]  W. Moon,et al.  Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer , 2020, Breast Cancer Research and Treatment.

[10]  D. Le Bihan,et al.  Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group , 2019, European Radiology.

[11]  P. V. van Diest,et al.  Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. , 2019, The New England journal of medicine.

[12]  S. Partridge,et al.  Diffusion-weighted MRI for Unenhanced Breast Cancer Screening. , 2019, Radiology.

[13]  Jun Xia,et al.  Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts , 2019, Breast Cancer Research and Treatment.

[14]  Colleen H. Neal,et al.  Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702) , 2019, Clinical Cancer Research.

[15]  T. Helbich,et al.  Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging , 2018, Investigative radiology.

[16]  W. Berg,et al.  Breast density implications and supplemental screening , 2018, European Radiology.

[17]  E. Morris,et al.  Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis , 2018, European Radiology.

[18]  H. Kim,et al.  Unenhanced magnetic resonance screening using fused diffusion-weighted imaging and maximum-intensity projection in patients with a personal history of breast cancer: role of fused DWI for postoperative screening , 2017, Breast Cancer Research and Treatment.

[19]  Junfeng Li,et al.  Comparison and Optimization of 3.0 T Breast Images Quality of Diffusion-Weighted Imaging with Multiple B-Values. , 2017, Academic radiology.

[20]  H. Kim,et al.  Characterization of tumor and adjacent peritumoral stroma in patients with breast cancer using high-resolution diffusion-weighted imaging: Correlation with pathologic biomarkers. , 2016, European journal of radiology.

[21]  Christoph I. Lee,et al.  Performance of DWI as a Rapid Unenhanced Technique for Detecting Mammographically Occult Breast Cancer in Elevated-Risk Women With Dense Breasts. , 2016, AJR. American journal of roentgenology.

[22]  D. Reich,et al.  National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain. , 2016, Journal of the American College of Radiology : JACR.

[23]  G. Angelelli,et al.  Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging. , 2016, Diagnostic and interventional imaging.

[24]  Matthew L. Olson,et al.  Diffusion-Weighted Breast Magnetic Resonance Imaging: A Semiautomated Voxel Selection Technique Improves Interreader Reproducibility of Apparent Diffusion Coefficient Measurements , 2016, Journal of computer assisted tomography.

[25]  Hee Jung Shin,et al.  Comparison of readout segmented echo planar imaging (EPI) and EPI with reduced field‐of‐VIew diffusion‐weighted imaging at 3t in patients with breast cancer , 2015, Journal of magnetic resonance imaging : JMRI.

[26]  F. Szczepankiewicz,et al.  Extrapolation-Based References Improve Motion and Eddy-Current Correction of High B-Value DWI Data: Application in Parkinson’s Disease Dementia , 2015, PloS one.

[27]  D. Le Bihan,et al.  Quantitative Non-Gaussian Diffusion and Intravoxel Incoherent Motion Magnetic Resonance Imaging: Differentiation of Malignant and Benign Breast Lesions , 2015, Investigative radiology.

[28]  F. Sardanelli,et al.  Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study. , 2014, AJR. American journal of roentgenology.

[29]  M. Oudkerk,et al.  Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis , 2014, European Radiology.

[30]  Wendy B DeMartini,et al.  Diffusion-weighted MRI: association between patient characteristics and apparent diffusion coefficients of normal breast fibroglandular tissue at 3 T. , 2014, AJR. American journal of roentgenology.

[31]  Tamaki Yamada,et al.  Investigation of the optimal b-value to detect breast tumors with diffusion weighted imaging by 1.5-T MRI , 2014, Cancer Imaging.

[32]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  C. Perou,et al.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  Peter R Luijten,et al.  Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: The influence of the choice of b‐values , 2010, Journal of magnetic resonance imaging : JMRI.

[35]  Wendy B DeMartini,et al.  Differential diagnosis of mammographically and clinically occult breast lesions on diffusion‐weighted MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[36]  Wendy B DeMartini,et al.  Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. , 2009, AJR. American journal of roentgenology.

[37]  T. Helbich,et al.  Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? , 2009, Radiology.

[38]  Stefano Ciatto,et al.  Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. , 2007, AJR. American journal of roentgenology.

[39]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.

[40]  T. M. Kolb,et al.  Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. , 2002, Radiology.

[41]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[42]  Sibel Kul,et al.  Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. , 2011, AJR. American journal of roentgenology.

[43]  Hiroshi Honda,et al.  Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging , 2010, European Radiology.